CYFRA 21-1 predicts efficacy of combined chemoimmunotherapy in patients with advanced non-small cell lung cancer: a prospective observational study.

Kataoka N, Katayama Y, Yamada T, Morimoto K, Takeda T, Okada A, Shiotsu S, Chihara Y, Hiranuma O, Yamada T, Ota T, Harada T, Hasegawa I, Nishioka N, Iwasaku M, Tokuda S, Takayama K

Open source

DOI: 10.21037/tlcr-24-190
Published: 2024 Aug 31
Container: Translational lung cancer research
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.21037/tlcr-24-190,
  title = {CYFRA 21-1 predicts efficacy of combined chemoimmunotherapy in patients with advanced non-small cell lung cancer: a prospective observational study.},
  author = {Kataoka N and Katayama Y and Yamada T and Morimoto K and Takeda T and Okada A and Shiotsu S and Chihara Y and Hiranuma O and Yamada T and Ota T and Harada T and Hasegawa I and Nishioka N and Iwasaku M and Tokuda S and Takayama K},
  year = {2024},
  journal = {Translational lung cancer research},
  doi = {10.21037/tlcr-24-190},
  url = {https://doi.org/10.21037/tlcr-24-190}
}

RIS

TY  - JOUR
TI  - CYFRA 21-1 predicts efficacy of combined chemoimmunotherapy in patients with advanced non-small cell lung cancer: a prospective observational study.
AU  - Kataoka N
AU  - Katayama Y
AU  - Yamada T
AU  - Morimoto K
AU  - Takeda T
AU  - Okada A
AU  - Shiotsu S
AU  - Chihara Y
AU  - Hiranuma O
AU  - Yamada T
AU  - Ota T
AU  - Harada T
AU  - Hasegawa I
AU  - Nishioka N
AU  - Iwasaku M
AU  - Tokuda S
AU  - Takayama K
PY  - 2024
JO  - Translational lung cancer research
DO  - 10.21037/tlcr-24-190
UR  - https://doi.org/10.21037/tlcr-24-190
ER  -

APA

N, K., Y, K., T, Y., K, M., T, T., A, O., S, S., Y, C., O, H., T, Y., T, O., T, H., I, H., N, N., M, I., S, T., & K, T. (2024). CYFRA 21-1 predicts efficacy of combined chemoimmunotherapy in patients with advanced non-small cell lung cancer: a prospective observational study.. Translational lung cancer research. https://doi.org/10.21037/tlcr-24-190

Source records

pubmed · retrieved 2026-09-27T00:18:48.109Z